About RexahnClinical DevelopmentTechbologiesPatientsInvestor RelationsMedia Center


 

 

 

 

 

 

 

 

 

 

exahn Pharmaceuticals is a clinical stage biopharmaceutical company, comprised of a world-class team of professionals dedicated to the

1

discovery, development and commercialization of innovative treatments for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. Innovative therapeutics and technologies come from a commitment to the wellness of the patients we serve.

 

July 14, 2008
Rexahn Pharmaceuticals Appoints Chief Business Officer
June 30, 2008
Rexahn Pharmaceuticals Added to Russell 3000 Index
June 26, 2008
Rexahn Pharmaceuticals Announces Publication of New Drug Discovery Tool
June 17, 2008
Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Anti-cancer Compound RX-0047

 

eikon.jpg cancernews.jpg mental.jpg